Which regimen is recommended for infective endocarditis in patients who are intravenous drug users?

Which regimen is recommended for infective endocarditis in patients who are intravenous drug users?

• A. Ceftriaxone + Gentamicin (if uncomplicated history)
• B. Rifampin + Gentamicin + Vancomycin (prosthetic valve)
• C. Vancomycin alone
• D. Nafcillin + Gentamicin + Vancomycin (IV drug user)

Answer: (D)

In intravenous drug users, infective endocarditis is most often caused by Staphylococcus aureus, including MRSA, so initial therapy must cover both MSSA and MRSA and achieve rapid, reliable killing. Nafcillin targets MSSA, vancomycin covers MRSA, and adding gentamicin provides synergistic bactericidal activity with a beta-lactam, helping to clear the infection more quickly in native-valve endocarditis. This combination therefore offers broad coverage for the likely organisms until culture results are back. If a prosthetic valve were involved, rifampin would be added to tackle biofilm, but for this scenario without a prosthetic valve, the triple regimen optimizes coverage and early bacterial kill.

In intravenous drug users, infective endocarditis is most often caused by Staphylococcus aureus, including MRSA, so initial therapy must cover both MSSA and MRSA and achieve rapid, reliable killing. Nafcillin targets MSSA, vancomycin covers MRSA, and adding gentamicin provides synergistic bactericidal activity with a beta-lactam, helping to clear the infection more quickly in native-valve endocarditis. This combination therefore offers broad coverage for the likely organisms until culture results are back. If a prosthetic valve were involved, rifampin would be added to tackle biofilm, but for this scenario without a prosthetic valve, the triple regimen optimizes coverage and early bacterial kill.